| mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |